Ming O. Li

Active 1996–2025

93
Papers
24,426
Citations
69
h-index
88
i10-index

Citations

Citations per year for Ming O. Li1994: 1 citations1996: 5 citations1997: 34 citations1998: 28 citations1999: 35 citations2000: 35 citations2001: 44 citations2002: 55 citations2003: 55 citations2004: 78 citations2005: 77 citations2006: 131 citations2007: 183 citations2008: 208 citations2009: 224 citations2010: 224 citations2011: 198 citations2012: 242 citations2013: 290 citations2014: 247 citations2015: 286 citations2016: 303 citations2017: 416 citations2018: 408 citations2019: 905 citations2020: 1,048 citations2021: 1,180 citations2022: 1,068 citations2023: 851 citations2024: 1,185 citations2025: 690 citations2026: 26 citations1995: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,091 citing papers, 30.6% of this breakdownChina: 2,588 citing papers, 19.4% of this breakdownUnited Kingdom: 776 citing papers, 5.8% of this breakdownGermany: 714 citing papers, 5.3% of this breakdownFrance: 482 citing papers, 3.6% of this breakdownJapan: 440 citing papers, 3.3% of this breakdownItaly: 406 citing papers, 3% of this breakdownAustralia: 318 citing papers, 2.4% of this breakdownCanada: 305 citing papers, 2.3% of this breakdownNetherlands: 247 citing papers, 1.9% of this breakdownSouth Korea: 246 citing papers, 1.8% of this breakdownSwitzerland: 228 citing papers, 1.7% of this breakdown
0%30.6%Other 18.9%

Fields

  • Immunology and Microbiology39.6%
  • Medicine33.2%
  • Biochemistry, Genetics and Molecular Biology22.4%
  • Neuroscience2.1%
  • Engineering0.9%
  • Agricultural and Biological Sciences0.6%
  • Other1.2%

Topics

  • Immune Cell Function and Interaction9.3%
  • T-cell and B-cell Immunology6.3%
  • Immune cells in cancer6.1%
  • Cancer Immunotherapy and Biomarkers4.5%
  • Immunotherapy and Immune Responses4.3%
  • CAR-T cell therapy research2%
  • Other67.5%

Coauthors

All papers

Open in search
  1. The cellular and molecular origin of tumor-associated macrophages

    Authors: , , , , , , , - Science 2014 cited by 1,423

  2. Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism

    Authors: , , , , , - Science 2016 cited by 786

  3. Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christina S. Leslie, Timothy A. Chan, A. Ari Hakimi - Cancer Cell 2021 cited by 439

  4. TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES

    Authors: , , , , - Annual Review of Immunology 2005 cited by 2,180

  5. Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Genome biology 2016 cited by 1,042

  6. Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection

    Authors: , , - Cold Spring Harbor Perspectives in Biology 2017 cited by 610

  7. Tumor-associated macrophages expressing the transcription factor IRF8 promote T cell exhaustion in cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , - Immunity 2022 cited by 188

  8. Reprogramming tumour-associated macrophages to outcompete cancer cells

    Authors: , , , , , , , , , , , , , , , , - Nature 2023 cited by 141

  9. Control of tumor-associated macrophage responses by nutrient acquisition and metabolism

    Authors: , , - Immunity 2023 cited by 121

  10. T cell receptor signalling in the control of regulatory T cell differentiation and function

    Authors: , - Nature reviews. Immunology 2016 cited by 482

  11. Innate immune cells in the tumor microenvironment

    Authors: , , , , , , , , , , - Cancer Cell 2021 cited by 136

  12. The Transcription Factor FoxO1 Sustains Expression of the Inhibitory Receptor PD-1 and Survival of Antiviral CD8+ T Cells during Chronic Infection

    Authors: , , , , , , , , - Immunity 2014 cited by 376

  13. Cancer immunotherapy via targeted TGF-β signalling blockade in TH cells

    Authors: , , , , , , , , , , , , , - Nature 2020 cited by 240

  14. TGFβ control of immune responses in cancer: a holistic immuno-oncology perspective

    Authors: , , , - Nature reviews. Immunology 2022 cited by 141

  15. Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells

    Authors: , , , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2012 cited by 599

  16. Glycolytic ATP fuels phosphoinositide 3-kinase signaling to support effector T helper 17 cell responses

    Authors: , , , , , , , , , , , , - Immunity 2021 cited by 112

  17. TGF-β: A Master of All T Cell Trades

    Authors: , - Cell 2008 cited by 890

  18. Lactate dehydrogenase A-dependent aerobic glycolysis promotes natural killer cell anti-viral and anti-tumor function

    Authors: , , , , , , , , - Cell Reports 2021 cited by 102

  19. Contextual Regulation of Inflammation: A Duet by Transforming Growth Factor-β and Interleukin-10

    Authors: , - Immunity 2008 cited by 493

  20. ESM1 enhances fatty acid synthesis and vascular mimicry in ovarian cancer by utilizing the PKM2-dependent warburg effect within the hypoxic tumor microenvironment

    Authors: , , , , , , , , , , , , , , , , , - Molecular Cancer 2024 cited by 89

  21. Distinct metabolic requirements regulate B cell activation and germinal center responses

    Authors: , , , , , , , , , , , , , , - Nature Immunology 2023 cited by 78

  22. mTORC1 and mTORC2 Kinase Signaling and Glucose Metabolism Drive Follicular Helper T Cell Differentiation

    Authors: , , , , , , , , , , , , , , - Immunity 2016 cited by 340

  23. TGF-β suppresses type 2 immunity to cancer

    Authors: , , , , , , , , , , , , , , , , - Nature 2020 cited by 188

  24. M2 macrophages mediate sorafenib resistance by secreting HGF in a feed-forward manner in hepatocellular carcinoma

    Authors: , , , , , , , , , , - British Journal of Cancer 2019 cited by 141